Antimicrobial Agents Practice Questions

Q: Which of the following antitubercular drugs has maximum cerebrospinal fluid (CSF) penetration?

Isoniazid (INH). **Explanation:** The penetration of antitubercular drugs into the cerebrospinal fluid (CSF) is a critical factor in managing Tuberculous Meningitis (TBM). **Why Isoniazid (INH) is Correct:** Isoniazid is a small, water-soluble molecule with low protein binding. It achieves excellent penetration into the CSF, reaching concentrations nearly **equal to those in the plasma** (approx. 90–100%), regardless of whether the meninges are inflamed or intact. This makes it the backbone of TBM treatment. Pyrazinamide (not listed here) also shares this property of excellent CSF penetration. **Analysis of Incorrect Options:** * **Streptomycin (Option A):** As an aminoglycoside, it is a large, polar molecule. It penetrates the blood-brain barrier (BBB) very poorly, even when meninges are inflamed. It is generally avoided in TBM unless resistance dictates otherwise. * **Rifampicin (Option C):** It is a large, lipid-soluble molecule but is highly protein-bound. It achieves only about 5–25% of plasma concentration in the CSF. While essential for treatment, its penetration is significantly lower than INH. * **Ethambutol (Option D):** It has poor CSF penetration (approx. 10–20%) and only crosses the BBB in significant amounts when the meninges are acutely inflamed. **High-Yield NEET-PG Pearls:** * **Best CSF Penetration:** Isoniazid and Pyrazinamide (reach therapeutic levels even without inflammation). * **Moderate CSF Penetration:** Rifampicin and Ethambutol (penetrate better when meninges are inflamed). * **Poor CSF Penetration:** Streptomycin and other aminoglycosides. * **Drug of Choice for TBM:** The standard intensive phase (HRZE) is used, but doses of Isoniazid and Pyrazinamide are most crucial for CNS efficacy. Corticosteroids (Dexamethasone) are often added to reduce neurological complications.

Q: What is the drug of choice for Kala-azar?

Liposomal amphotericin B. **Explanation:** **Kala-azar (Visceral Leishmaniasis)** is caused by *Leishmania donovani*. The current **Drug of Choice (DOC)**, as per WHO and National Vector Borne Disease Control Programme (NVBDCP) guidelines, is **Liposomal Amphotericin B (LAmB)**. 1. **Why Liposomal Amphotericin B is correct:** Amphotericin B acts by binding to ergosterol in the fungal/protozoal cell membrane, creating pores. The **liposomal formulation** is preferred because it specifically targets the Reticuloendothelial System (liver and spleen) where the *Leishmania* parasites reside. It offers high efficacy (>95% cure rate) with a single-dose infusion (10 mg/kg) and significantly lower nephrotoxicity compared to the conventional deoxycholate form. 2. **Why other options are incorrect:** * **Sodium Stibogluconate (SSG):** Historically the DOC, but now largely abandoned in the Indian subcontinent (especially Bihar) due to widespread **antimonial resistance** and severe cardiotoxicity (QT prolongation). * **Pentamidine:** Previously used as a second-line agent, but its use is limited by severe side effects like insulin-dependent diabetes mellitus, hypotension, and renal failure. * **Ketoconazole:** An oral antifungal that has some activity against cutaneous leishmaniasis but is **ineffective** for the visceral form (Kala-azar). **High-Yield Clinical Pearls for NEET-PG:** * **Miltefosine:** The only **oral** drug for Kala-azar; however, it is teratogenic (contraindicated in pregnancy). * **Post-Kala-azar Dermal Leishmaniasis (PKDL):** The DOC is also Liposomal Amphotericin B (though treatment duration is longer). * **Vector:** Transmitted by the bite of the female sandfly (*Phlebotomus argentipes*). * **Diagnosis:** The gold standard is the demonstration of **LD bodies** in splenic or bone marrow aspirates; **rK39** is the rapid diagnostic test of choice.

Q: Cotrimoxazole is the drug of choice for:

Nocardia. **Explanation:** **Cotrimoxazole** (a fixed-dose combination of Sulfamethoxazole and Trimethoprim) is the **drug of choice for Nocardiosis** caused by *Nocardia asteroides*. 1. **Why Nocardia is Correct:** *Nocardia* is an aerobic, Gram-positive, filamentous bacterium that is partially acid-fast. Cotrimoxazole acts by inhibiting two consecutive steps in the bacterial synthesis of folic acid (sequential blockade). It is highly effective against *Nocardia*, and long-term therapy (6–12 months) is the standard of care for pulmonary, cutaneous, and disseminated forms of the disease. 2. **Why Actinomyces is Incorrect:** Although *Actinomyces* is also a Gram-positive filamentous bacterium, it is an **anaerobe** and is **not acid-fast**. The drug of choice for Actinomycosis is **Penicillin G** (or Amoxicillin). While Cotrimoxazole has some activity, it is not the preferred first-line agent. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Sulfamethoxazole inhibits Dihydropteroate synthase; Trimethoprim inhibits Dihydrofolate reductase. * **Other Drugs of Choice for Cotrimoxazole:** * *Pneumocystis jirovecii* (Prophylaxis and Treatment) * *Stenotrophomonas maltophilia* * *Burkholderia cepacia* * *Toxoplasma gondii* (Prophylaxis) * **Distinguishing Feature:** Remember the mnemonic **"SNAP"**: **S**ulfonamides for **N**ocardia, **A**ctinomyces treated with **P**enicillin. * **Adverse Effects:** Look out for Stevens-Johnson Syndrome (SJS), crystalluria, and megaloblastic anemia in patients with borderline folate levels.

Q: Which antimicrobial agent's dose is reduced in renal failure?

Rifabutin. **Explanation** The management of antimicrobial dosing in renal failure is a high-yield topic for NEET-PG. The core principle is that drugs primarily excreted by the kidneys require dose adjustment (reduction or interval extension) to prevent accumulation and toxicity. **Why Rifabutin is the Correct Answer:** Rifabutin, a rifamycin derivative used in tuberculosis and MAC prophylaxis, undergoes significant renal excretion (approximately 10-25% as unchanged drug and metabolites). In patients with severe renal impairment (CrCl < 30 mL/min), the dose must be reduced by 50% to avoid systemic toxicity. **Analysis of Incorrect Options:** * **Isoniazid (INH):** Primarily metabolized by the liver via acetylation (NAT2 enzyme). Dose adjustment is generally not required in renal failure, though it is often supplemented after dialysis. * **Ethambutol:** While 80% is excreted renally, it is typically managed by **increasing the dosing interval** (e.g., from 24 hours to 48 hours) rather than a simple dose reduction, though some guidelines vary. However, in the context of this specific MCQ, Rifabutin is the more definitive choice for dose reduction. * **Kanamycin:** As an aminoglycoside, it is highly nephrotoxic and excreted renally. However, in clinical practice, aminoglycosides are often avoided entirely in renal failure or managed via strict Therapeutic Drug Monitoring (TDM) rather than a standardized "dose reduction" in the same manner as Rifabutin. **NEET-PG High-Yield Pearls:** 1. **Safe in Renal Failure:** Rifampicin, Isoniazid, Pyrazinamide, Doxycycline, and Ceftriaxone (dual excretion). 2. **Avoid/Adjust in Renal Failure:** Ethambutol, Aminoglycosides, Vancomycin, and Clarithromycin. 3. **Rifabutin vs. Rifampin:** Rifabutin is preferred in HIV patients on Protease Inhibitors because it is a less potent inducer of Cytochrome P450 enzymes compared to Rifampin.

Q: Which of the following adverse reactions absolutely contraindicates further use of rifampicin in the treatment of tuberculosis?

Respiratory syndrome. **Explanation:** Rifampicin is a cornerstone of anti-tubercular therapy (ATT), but it is associated with several immune-mediated adverse reactions, particularly when administered intermittently or after a period of drug interruption. These reactions are categorized into four major syndromes: 1. **Respiratory Syndrome (Correct Answer):** This is the most severe reaction and is characterized by dyspnea, wheezing, and occasionally pulmonary edema or shock. It is considered a **life-threatening hypersensitivity reaction**. Because of the high risk of fatal anaphylaxis or severe respiratory failure upon re-exposure, it is an **absolute contraindication** to further use of the drug. 2. **Cutaneous Syndrome (Option B):** Presents as flushing, itching, or a rash. While uncomfortable, it is usually self-limiting and can often be managed with antihistamines without discontinuing the drug. 3. **Flu-like Syndrome (Option C):** Characterized by fever, chills, and body aches. It is the most common reaction to intermittent dosing. It is generally managed by switching to a daily dosing schedule rather than permanent discontinuation. 4. **Abdominal Syndrome (Option D):** Involves nausea, vomiting, and abdominal pain. It is usually mild and does not necessitate stopping the drug unless it is associated with hepatotoxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits DNA-dependent RNA polymerase. * **Other Absolute Contraindications:** Acute Renal Failure and Hemolytic Anemia (both are rare but serious immune-mediated reactions). * **Red-Orange Discoloration:** Rifampicin causes harmless orange-red discoloration of urine, sweat, and tears; patients should be warned to avoid staining contact lenses. * **Enzyme Induction:** It is a potent inducer of Cytochrome P450 enzymes, leading to significant drug interactions (e.g., reducing the efficacy of oral contraceptives and warfarin).

Q: All of the following antibiotics are 50S ribosomal inhibitors, EXCEPT?

Streptomycin. Protein synthesis inhibitors are a high-yield topic for NEET-PG. These drugs work by binding to either the 30S or 50S subunits of the bacterial ribosome [1]. Why Streptomycin is the correct answer: Streptomycin is an **Aminoglycoside** [3]. Aminoglycosides (along with Tetracyclines) bind to the **30S ribosomal subunit** [2, 1]. They interfere with the initiation complex, cause misreading of mRNA, and break up polysomes into non-functional monosomes [2]. Because it acts on the 30S subunit, it is the exception in this list. Analysis of Incorrect Options (50S Inhibitors): * **Chloramphenicol:** Binds to the 50S subunit and inhibits the enzyme **peptidyl transferase**, preventing peptide bond formation [1]. * **Erythromycin:** A Macrolide that binds to the 50S subunit and inhibits **translocation** (the movement of tRNA from the A-site to the P-site) [1]. * **Linezolid:** An Oxazolidinone that binds to the 23S fraction of the 50S subunit. It is unique because it prevents the **formation of the 70S initiation complex** [1]. Clinical Pearls for NEET-PG: * **Mnemonic for 50S inhibitors:** "**C**EL" (**C**hloramphenicol, **E**rythromycin/Macrolides, **L**inezolid/Clindamycin). * **Mnemonic for 30S inhibitors:** "**A**T" (**A**minoglycosides, **T**etracyclines). * **Aminoglycosides** are the only protein synthesis inhibitors that are **bactericidal** (most others are bacteriostatic) [3]. * **Linezolid** is a drug of choice for MRSA and VRE but can cause **thrombocytopenia** and **Serotonin Syndrome** when co-administered with SSRIs.

Q: Which drug is NOT used in the treatment of visceral leishmaniasis?

Hydroxychloroquine. **Explanation:** Visceral Leishmaniasis (Kala-azar), caused by *Leishmania donovani*, requires specific antiprotozoal therapy. **Hydroxychloroquine (Option D)** is the correct answer because it is an antimalarial and immunomodulatory drug (used in SLE and Rheumatoid Arthritis) with no clinical efficacy against *Leishmania* species. **Analysis of Options:** * **Stibogluconate (Option A):** A pentavalent antimonial (SbV) that was historically the first-line treatment. However, significant resistance has developed, particularly in the Bihar region of India. * **Paromomycin (Option B):** An aminoglycoside antibiotic that acts as a potent leishmanicidal agent by inhibiting protein synthesis. It is often used in combination therapies. * **Miltefosine (Option C):** This is the **only oral drug** available for visceral leishmaniasis. It is highly effective but contraindicated in pregnancy due to its teratogenic potential. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Liposomal **Amphotericin B** is currently the drug of choice for Visceral Leishmaniasis in India (single dose 10mg/kg). * **Post-Kala-azar Dermal Leishmaniasis (PKDL):** Miltefosine is commonly used for the extended treatment required in PKDL cases. * **Vector:** The disease is transmitted by the bite of the female sandfly (*Phlebotomus argentipes*). * **Diagnostic Gold Standard:** Demonstration of LD bodies (Amastigotes) in splenic or bone marrow aspirates. The rK39 rapid antigen test is used for field diagnosis.

Q: Which of the following agents does not cause pseudomembranous enterocolitis?

Vancomycin. **Explanation:** **Pseudomembranous enterocolitis** is caused by the overgrowth of *Clostridioides difficile* (C. diff) following the suppression of normal intestinal flora by broad-spectrum antibiotics. **Why Vancomycin is the correct answer:** Vancomycin (specifically the oral formulation) is actually a **treatment** for pseudomembranous enterocolitis. It is a glycopeptide antibiotic that is not absorbed from the GI tract, allowing it to reach high concentrations in the colon where it kills *C. difficile*. Because it targets the causative organism rather than predisposing the patient to its overgrowth, it does not cause the condition. **Analysis of incorrect options:** Almost any antibiotic can theoretically cause C. diff infection, but certain classes are notorious "high-risk" triggers: * **Clindamycin (Option C):** Historically the most classically associated antibiotic with pseudomembranous colitis. * **Ceftazidime (Option D):** 3rd and 4th generation Cephalosporins are currently the most common triggers in hospital settings due to their broad-spectrum activity. * **Levofloxacin (Option B):** Fluoroquinolones are frequently implicated in outbreaks and are major risk factors for C. diff. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** Oral Vancomycin or Fidaxomicin are the first-line treatments for C. diff. * **Metronidazole:** Previously the first-line agent, it is now reserved for mild cases if Vancomycin is unavailable. * **Mechanism:** *C. difficile* produces Toxin A (enterotoxin) and Toxin B (cytotoxin); Toxin B is primarily responsible for the mucosal damage and "pseudomembrane" formation. * **Diagnosis:** Confirmed by detecting C. diff toxins in stool or via sigmoidoscopy showing yellow-white plaques.

Q: All of the following toxicities are known with linezolid, EXCEPT:

Vomiting. **Explanation:** Linezolid is an oxazolidinone antibiotic used primarily for resistant Gram-positive infections like MRSA and VRE. The question asks for the exception among its known toxicities. While gastrointestinal upset can occur with many antibiotics, **Vomiting** is not considered a characteristic or "signature" toxicity of linezolid in the context of medical examinations, whereas the other options are classic, high-yield side effects associated with its unique mechanism of action. **Analysis of Options:** * **Thrombocytopenia (Option A):** This is the most common hematologic abnormality. Linezolid causes reversible bone marrow suppression (myelosuppression), particularly when used for more than 2 weeks. Monitoring CBC is mandatory. * **Lactic Acidosis (Option B):** Linezolid can inhibit mitochondrial protein synthesis. This mitochondrial toxicity leads to a shift toward anaerobic metabolism, resulting in lactic acidosis. * **Peripheral Neuropathy (Option D):** Long-term use (usually >28 days) is strongly associated with both peripheral and optic neuropathy. Optic neuropathy can lead to vision loss and requires immediate discontinuation. **Clinical Pearls for NEET-PG:** 1. **MAO Inhibition:** Linezolid is a non-selective inhibitor of Monoamine Oxidase (MAO). It can precipitate **Serotonin Syndrome** if co-administered with SSRIs or tyramine-rich foods. 2. **Mechanism:** It inhibits protein synthesis by binding to the **23S ribosomal RNA of the 50S subunit**, preventing the formation of the 70S initiation complex. 3. **Resistance:** Resistance occurs via mutations in the 23S rRNA. 4. **Bioavailability:** It has nearly **100% oral bioavailability**, allowing an easy switch from IV to oral dosing.

Q: Which drug is useful in treating chloroquine-resistant malaria?

Mefloquine. The treatment of chloroquine-resistant *Plasmodium falciparum* (CRPF) requires drugs that remain effective despite the parasite's efflux mechanisms. **Mefloquine** is a high-yield choice for this purpose [1, 2].

Question 1

Which of the following antitubercular drugs has maximum cerebrospinal fluid (CSF) penetration?

Accepted Answer

Isoniazid (INH)

Answer

Streptomycin

Answer

Rifampicin

Answer

Ethambutol

Question 2

What is the drug of choice for Kala-azar?

Accepted Answer

Liposomal amphotericin B

Answer

Pentamidine

Answer

Sodium stibogluconate

Answer

Ketoconazole

Question 3

Cotrimoxazole is the drug of choice for:

Accepted Answer

Nocardia

Answer

Actinomyces

Answer

Both Actinomyces and Nocardia

Answer

None of the above

Question 4

Which antimicrobial agent's dose is reduced in renal failure?

Accepted Answer

Rifabutin

Answer

Isoniazid (INH)

Answer

Ethambutol

Answer

Kanamycin

Question 5

Which of the following adverse reactions absolutely contraindicates further use of rifampicin in the treatment of tuberculosis?

Accepted Answer

Respiratory syndrome

Answer

Cutaneous syndrome

Answer

Flu-like syndrome

Answer

Abdominal syndrome

Question 6

All of the following antibiotics are 50S ribosomal inhibitors, EXCEPT?

Accepted Answer

Streptomycin

Answer

Chloramphenicol

Answer

Erythromycin

Answer

Linezolid

Question 7

Which drug is NOT used in the treatment of visceral leishmaniasis?

Accepted Answer

Hydroxychloroquine

Answer

Stibogluconate

Answer

Paromomycin

Answer

Miltefosine

Question 8

Which of the following agents does not cause pseudomembranous enterocolitis?

Accepted Answer

Vancomycin

Answer

Levofloxacin

Answer

Clindamycin

Answer

Ceftazidime

Question 9

All of the following toxicities are known with linezolid, EXCEPT:

Accepted Answer

Vomiting

Answer

Thrombocytopenia

Answer

Lactic acidosis

Answer

Peripheral neuropathy

Question 10

Which drug is useful in treating chloroquine-resistant malaria?

Accepted Answer

Mefloquine

Answer

Proguanil

Answer

Pyrimethamine

Answer

Primaquine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?